Pulmatrix (PULM) Common Equity (2016 - 2025)
Pulmatrix (PULM) has disclosed Common Equity for 13 consecutive years, with $3.8 million as the latest value for Q4 2025.
- Quarterly Common Equity fell 57.42% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 57.42% year-over-year, with the annual reading at $3.8 million for FY2025, 57.42% down from the prior year.
- Common Equity hit $3.8 million in Q4 2025 for Pulmatrix, down from $4.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $56.6 million in Q1 2021 to a low of $3.8 million in Q4 2025.
- Historically, Common Equity has averaged $25.6 million across 5 years, with a median of $21.7 million in 2023.
- Biggest five-year swings in Common Equity: surged 716.7% in 2021 and later tumbled 62.42% in 2025.
- Year by year, Common Equity stood at $47.4 million in 2021, then crashed by 34.44% to $31.1 million in 2022, then plummeted by 42.16% to $18.0 million in 2023, then plummeted by 50.28% to $8.9 million in 2024, then crashed by 57.42% to $3.8 million in 2025.
- Business Quant data shows Common Equity for PULM at $3.8 million in Q4 2025, $4.7 million in Q3 2025, and $5.6 million in Q2 2025.